Delivery Order SPE2DB25D3020-SPE2DB25FWKCB
Award Date 8/19/25
Potential Completion Date 8/20/25
Potential Value $4.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $62,896.54 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Otezla is a prescription medication used to treat psoriasis, psoriatic arthritis, and ankylosing...
- The Defense Logistics Agency awarded a delivery order valued at $5,085.83 to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order represents a non-competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Otezla is a prescription medication used to treat psoriasis, psoriatic arthritis, and ankylosing spondylitis, supporting...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,311.62 on September 15, 2025, for Otezla 20 mg tablets (60-count supply). This is a firm fixed-price, non-competitive delivery order with an ultimate completion date of September 16, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Otezla is a prescription medication used primarily to treat psoriasis, psoriatic arthritis, and behçet's disease. This...
- The Defense Logistics Agency awarded a delivery order valued at $18,874.86 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on August 20, 2025, with a completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $16,471.83 to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Otezla 30 mg tablets (60-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by June 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Otezla is a pharmaceutical treatment commonly used for psoriasis, psoriatic arthritis,...
- The Defense Logistics Agency awarded a delivery order valued at $4,576.65 to AmerisourceBergen Drug Corp for Otezla 30 mg tablets (60-count supply) on July 24, 2025, with a completion date of July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Otezla is a prescription immunosuppressant medication used to treat various inflammatory...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp for Otezla 30 mg tablets in a quantity of 60 units, valued at $15,493.97. The award was made on June 2, 2025, with an ultimate completion date of June 3, 2025. This non-set-aside delivery order was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Otezla (apremilast) is a immunosuppressive medication commonly used to treat psoriasis and...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2023, for the supply of Otezla 30 mg tablets (60-count) with a ceiling value of approximately $31,000. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open procurement process. The order is scheduled for completion by October 13, 2023, and will be fulfilled from AmerisourceBergen's corporate office located in...
- The Defense Logistics Agency awarded a delivery order valued at $5,026.45 to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg on August 14, 2025, with a completion date of August 15, 2025. This firm fixed price delivery order represents a non-set-aside, competitively awarded contract and is part of a larger Indefinite Delivery Contract (IDC) vehicle—the DLA Troop Support Medical contract SPE2DX valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order valued at $9,760.98 to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg, a pharmaceutical product used primarily for treating plaque psoriasis and psoriatic arthritis. This firm fixed price delivery order, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-competitive, non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...